Evolus (EOLS) Operating Expenses (2017 - 2026)
Evolus (EOLS) posted Operating Expenses of $55.7 million for Q1 2026, up 1.22% on a QoQ basis from $55.1 million in Q4 2025, and down 9.84% year-over-year from $61.8 million in Q1 2025.
Evolus (EOLS) Operating Expenses (2017 - 2026) Analysis & Trends
Evolus' Operating Expenses history runs 10 years deep, the most recent figure standing at $55.7 million for Q1 2026.
- Quarterly Operating Expenses fell 9.84% year-over-year to $55.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $223.7 million (down 2.37% YoY) and the FY2025 annual result came in at $229.8 million, up 6.02% from the prior year.
- Operating Expenses was $55.7 million for Q1 2026 at Evolus, up from $55.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $64.5 million in Q2 2023 and bottomed at -$4.6 million in Q4 2022.
- A 5-year average of $49.7 million and a median of $55.1 million in 2025 frame the typical range for Operating Expenses.
- Peak annual rise in Operating Expenses reached 1070.96% in 2022, while the deepest fall reached 108.65% in 2022.
- Evolus' Operating Expenses stood at -$4.6 million in 2022, then surged by 212.31% to $5.1 million in 2023, then surged by 973.2% to $54.9 million in 2024, then increased by 0.22% to $55.1 million in 2025, then rose by 1.22% to $55.7 million in 2026.
- Business Quant data shows EOLS's Operating Expenses at $55.7 million in Q1 2026, $55.1 million in Q4 2025, and $57.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Evolus | 393.73 Mn | 343.94 Mn | 48.90 Mn | 55.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.75 Mn |
| Dec 31, 2025 | 55.07 Mn |
| Sep 30, 2025 | 57.34 Mn |
| Jun 30, 2025 | 55.53 Mn |
| Mar 31, 2025 | 61.83 Mn |
| Dec 31, 2024 | 54.95 Mn |
| Sep 30, 2024 | 57.57 Mn |
| Jun 30, 2024 | 54.77 Mn |
| Mar 31, 2024 | 49.43 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Sep 30, 2023 | 63.46 Mn |
| Jun 30, 2023 | 64.46 Mn |
| Mar 31, 2023 | 53.76 Mn |
| Dec 31, 2022 | -4.56 Mn |
| Sep 30, 2022 | 51.80 Mn |
| Jun 30, 2022 | 58.51 Mn |
| Mar 31, 2022 | 49.36 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 45.79 Mn |
| Jun 30, 2021 | 41.39 Mn |